Aurum Ventures M.K.I

Aurum Ventures M.K.I Overview

Aurum Ventures M.K.I provides financing and other managerial resources to life science companies in all stages of development, with a geographical focus on Israeli and Israel-related opportunities. The company is centered on innovative therapeutics devices and pharmaceuticals but will occasionally consider non-therapeutics, such as agricultural biotechnology or bioenergy. It invests alone or together with other reliable partners in either a lead or follower position. While focusing on investing in cutting-edge technologies that will mature into successful businesses, Aurum's investments reflect its own values, so it prefers investing in companies that, through their sound commercial propositions, also contribute to the wellbeing of humankind. Aurum Ventures M.K.I is the technology investment arm of businessman, philanthropist, and entrepreneur Morris Kahn.

Latest News

May 25, 2016 · multiplesclerosisnewstoday.com

growth-positive

https://multiplesclerosisnewstoday.com/2016/05/25/diagnostic-blood-test-of-rrms-to-made-possible-by-aurum-ventures-investment/

Yissum Research Development Company has partnered with Aurum Ventures MKI to develop a diagnostic blood test for relapsing-remitting multiple sclerosis (RRMS) and other diseases. The test uses differences in DNA from dying cells found in the blood of sick individuals. Yissum received a $1.2 million investment from Aurum Ventures for the development of the diagnostic tool. The technology has the potential to detect diseases at their asymptomatic stage and has a first priority in neurodegenerative, cardiovascular, and autoimmune diseases.

Investment

Team Members

6

Web & Social Links

Locations

Abba Hillel Silver Road 16, Ramat Gan, Israel

Photos & Videos

No files yet

Aurum Ventures M.K.I Internal

Recent Updates

Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.

Admin Info